OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and fibrosis in murine models of heart failure
Lucas Bacmeister, Michael Schwarzl, Svenja Warnke, et al.
Basic Research in Cardiology (2019) Vol. 114, Iss. 3
Closed Access | Times Cited: 317

Showing 1-25 of 317 citing articles:

New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury
Jin Wang, Sam Toan, Hao Zhou
Angiogenesis (2020) Vol. 23, Iss. 3, pp. 299-314
Closed Access | Times Cited: 269

Resolving the intertwining of inflammation and fibrosis in human heart failure at single-cell level
Man Rao, Xiliang Wang, Guangran Guo, et al.
Basic Research in Cardiology (2021) Vol. 116, Iss. 1
Closed Access | Times Cited: 140

The Role of Interleukin-6 Family Members in Cardiovascular Diseases
Yongqi Feng, Di Ye, Zhen Wang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 74

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 41

Targeting MAPK-ERK/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure
Zeyu Zhang, Zhihua Yang, Shuai Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116413-116413
Open Access | Times Cited: 20

Flavonoids: Potential therapeutic agents for cardiovascular disease
Yingxue Liu, Jing Luo, Peng Lin, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32563-e32563
Open Access | Times Cited: 15

SERCA Overexpression Improves Mitochondrial Quality Control and Attenuates Cardiac Microvascular Ischemia-Reperfusion Injury
Ying Tan, David Mui, Sam Toan, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 22, pp. 696-707
Open Access | Times Cited: 123

BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs
Patrícia Cristine Borck, Lian‐Wang Guo, Jorge Plutzky
Circulation Research (2020) Vol. 126, Iss. 9, pp. 1190-1208
Open Access | Times Cited: 119

Upregulation of Circular RNA CircNFIB Attenuates Cardiac Fibrosis by Sponging miR-433
Yujiao Zhu, Wen Pan, Tingting Yang, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 101

Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts
Tingting Li, Yuting Zhuang, Wanqi Yang, et al.
The FASEB Journal (2020) Vol. 35, Iss. 2
Closed Access | Times Cited: 97

Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models
Minru Liao, Qiang Xie, Yuqian Zhao, et al.
Pharmacological Research (2022) Vol. 176, pp. 106077-106077
Closed Access | Times Cited: 57

Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
Cuncun Hua, Xinming Liu, Lirong Liang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 55

Based on network pharmacology and in vitro experiments to prove the effective inhibition of myocardial fibrosis by Buyang Huanwu decoction
Tianyue Wang, Xinyu Jiang, Yanmin Ruan, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13767-13783
Open Access | Times Cited: 50

Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways
Guang‐Hong Chen, Honglin Xu, Tong Xu, et al.
Phytomedicine (2022) Vol. 104, pp. 154277-154277
Closed Access | Times Cited: 48

Panaxatriol saponin ameliorates myocardial infarction-induced cardiac fibrosis by targeting Keap1/Nrf2 to regulate oxidative stress and inhibit cardiac-fibroblast activation and proliferation
Huan Yao, Qingman He, Cong Huang, et al.
Free Radical Biology and Medicine (2022) Vol. 190, pp. 264-275
Closed Access | Times Cited: 44

Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT–IKK/STAT3 Axis
Xiaoping Wang, Weili Li, Yawen Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40

Role of emodin in atherosclerosis and other cardiovascular diseases: Pharmacological effects, mechanisms, and potential therapeutic target as a phytochemical
Xinyue Wang, Shengjie Yang, Yujuan Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114539-114539
Open Access | Times Cited: 23

Pharmacological properties of Polygonatum and its active ingredients for the prevention and treatment of cardiovascular diseases
Hongyuan Lin, Wenhui Wang, Mengqi Peng, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top